Literature DB >> 6233286

"Redo" surgery for late aorto-femoral graft occlusive failures.

A C Benhamou, E Kieffer, J F Tricot, M Maraval, M Le Thoai, J Natali.   

Abstract

Experience of late failures of Dacron aortofemoral grafts is presented; about 70 cases observed during the past eight years on whom 105 subsequent operations were performed. One third of these patients were first operated upon by another surgical team. During the same period, 850 patients were submitted to reconstructive surgery of the abdominal aorta and iliac arteries either for atherosclerotic or for aneurysmal disease. It appears that conservative procedures like thrombectomy of the occluded limb are often insufficient, impossible, inappropriate or dangerous, even after restoration of a good deep femoral outflow. On the other hand, aggressive restoration of limbflow is generally necessary, with other various and ingenious direct or indirect reconstructive techniques for restitution of a good inflow and outflow. These techniques are usually successful (85%) and gain time against the major etiology of these late failures viz the development of atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233286

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease.

Authors:  Salvatore T Scali; Bradley M Schmit; Robert J Feezor; Adam W Beck; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber
Journal:  J Vasc Surg       Date:  2014-03-21       Impact factor: 4.268

2.  Contemporary outcomes of thoracofemoral bypass.

Authors:  Jeffrey D Crawford; Salvatore T Scali; Kristina A Giles; Martin R Back; Javairiah Fatima; Dean K Arnaoutakis; Scott A Berceli; Gilbert J Upchurch; Thomas S Huber
Journal:  J Vasc Surg       Date:  2018-10-03       Impact factor: 4.268

3.  [Transplant occlusion following aortofemoral bifurcation bypass: causes, therapeutic measures and results].

Authors:  W Hepp; K de Jonge; M Langer
Journal:  Langenbecks Arch Chir       Date:  1984
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.